Person profile
Public information reviewedMark Fishman, M.D.
Board role
Lead Independent Director (Class II) · Beam Therapeutics Inc. (NASDAQ: BEAM)
Beam Therapeutics Inc. (NASDAQ: BEAM)
Lead Independent Director (Class II) · Current mandate
Board Director · Us Listed
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 6, 2026
Alpha Registry